These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 413305)

  • 1. Hemophiliac with hemolytic anemia resulting from factor VIII concentrate.
    Soni NS; Patel AR; Vohra RM; Shah PC
    Acta Haematol; 1977; 58(5):294-7. PubMed ID: 413305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemolytic anemia due to anti-B in antihemophiliac factor concentrates.
    Ashenhurst JB; Langehennig PL; Seeler RA; Telfer MC
    J Pediatr; 1976 Feb; 88(2):257-8. PubMed ID: 1249687
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-A in factor VIII concentrate: a cause of severe hemolysis in a patient with acquired factor VIII:C antibodies.
    Hach-Wunderle V; Teixidor D; Zumpe P; Kühnl P; Scharrer I
    Infusionstherapie; 1989 Jun; 16(3):100-1. PubMed ID: 2503450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemolytic anemia and F. VIII concentrate.
    Girelli G
    Eur J Haematol; 1989 Apr; 42(4):414. PubMed ID: 2498124
    [No Abstract]   [Full Text] [Related]  

  • 5. [Case of hemolytic anemia following treatment with cryobulin].
    Pluta A; Kniaź M; Kowalewski J
    Wiad Lek; 1980 Apr; 33(7):555-7. PubMed ID: 6771920
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemolysis caused by factor VIII concentrates.
    Orringer EP; Koury MJ; Blatt PM; Roberts HR
    Arch Intern Med; 1976 Sep; 136(9):1018-20. PubMed ID: 962445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Severe serogenic hemolytic anemia caused by anti-D fraction in factor VIII concentrate].
    Schricker KT; Schrenk KH
    Thromb Diath Haemorrh; 1972 Jul; 27(3):523-8. PubMed ID: 4197045
    [No Abstract]   [Full Text] [Related]  

  • 8. Acquired hemolytic anemia and thrombocytopenia (Evans' syndrome) in hemophilia.
    Harris PJ; Kessler CM; Lessin LS
    N Engl J Med; 1983 Jul; 309(1):50. PubMed ID: 6406894
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study on the levels of anti-A, anti-B isoagglutinin titer in various kinds of concentrates for hemophilia treatment--with special regard to the manufacturing process of factor VIII concentrate].
    Tomita Y; Inagaki M; Taki M; Miura T; Saito N; Sato R; Meguro T; Yamada K
    Rinsho Ketsueki; 1985 Feb; 26(2):166-70. PubMed ID: 3927035
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hemolytic anemia caused by graft-versus-host reaction in ABO-nonidentical renal transplants from blood group O donors].
    Peces R; Díaz Corte C; Navascués RA
    Nefrologia; 2001; 21(4):395-401. PubMed ID: 11816517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic differences among bovine and porcine Factor VIII concentrates.
    Edson JR; Swinehart CD
    Am J Clin Pathol; 1976 Jun; 65(6):957-63. PubMed ID: 59540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A.
    Hsu HC; Chen YF; Ho CH
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jul; 62(7):450-4. PubMed ID: 10418180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemolytic anemia due to anti-A in concentrated antihemophilic factor preparations.
    Rosati LA; Barnes B; Oberman HA; Penner JA
    Transfusion; 1970; 10(3):139-41. PubMed ID: 5422224
    [No Abstract]   [Full Text] [Related]  

  • 14. Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group.
    Lusher JM; Arkin S; Abildgaard CF; Schwartz RS
    N Engl J Med; 1993 Feb; 328(7):453-9. PubMed ID: 8421474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood products used in the treatment of hemophilia.
    Krasnoff AR; Mangione RA
    Hosp Pharm; 1982 Nov; 17(11):598-9, 602-4. PubMed ID: 10318549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of recombinant activated factor VII during surgery in a hemophiliac with high-titer factor VIII antibody.
    Gringeri A; Santagostino E; Mannucci PM
    Haemostasis; 1991; 21(1):1-4. PubMed ID: 1907588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaphylactic reactions following infusion of factor VIII in a patient with classic hemophilia.
    Helmer RE; Alperin JB; Yunginger JW; Grant JA
    Am J Med; 1980 Dec; 69(6):953-7. PubMed ID: 6160766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgery for a chronic cystic hematoma on the right thigh in a hemophiliac A with a potent factor VIII inhibitor.
    Masuhara K; Shimizu T; Kawasaki N; Fukui H; Sakai Y; Shima M; Mikami S; Yoshioka A
    Nihon Seikeigeka Gakkai Zasshi; 1982 Dec; 56(12):1719-27. PubMed ID: 6820658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemolytic anemia caused by infusion of factor VIII concentrates--a case report of hemophilia A with intracranial hemorrhage].
    Fukazawa K; Okuyama T; Manabe H; Kanaya J
    Rinsho Ketsueki; 1983 Jul; 24(7):892-6. PubMed ID: 6415317
    [No Abstract]   [Full Text] [Related]  

  • 20. Some complications of the therapy of classic hemophilia.
    Ratnoff OD
    J Lab Clin Med; 1984 May; 103(5):653-9. PubMed ID: 6425440
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.